Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00596232 · ClinicalTrials.gov registry record
Investigating Mucinase Activity in Airway Disease
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 211
- Enrollment target
NCT00596232 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 211 participants.
The verdict
NCT00596232 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 211 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate how mucus (phlegm or spit) is broken down once it forms in the airways (bronchial tubes) of people with lung disease. This research study will also examine whether blood groups have an effect on lung function or the type of mucus found in the lung. This study is not designed to be a treatment for asthma, emphysema, cystic fibrosis, or other lung disease. It is designed to help the investigators learn more about the causes of airway disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2003-04 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00596232
The ClinicalTrials.gov registry entry for NCT00596232 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00596232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00596232 about?
NCT00596232 is a clinical study titled "Investigating Mucinase Activity in Airway Disease". The purpose of this study is to investigate how mucus (phlegm or spit) is broken down once it forms in the airways (bronchial tubes) of people with lung disease. This research study will also examine whether blood groups have an effect on lung function or the type of mucus found in the lung. This st...
What is the current status of trial NCT00596232?
This trial is currently completed. The enrollment target is 211 participants. The study started on 2003-04. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT00596232?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.